Near-Infrared Intraoperative Imaging Can Successfully Identify Malignant Pleural Mesothelioma After Neoadjuvant Chemotherapy. (29th August 2017)

• Record Type: Journal Article
• Authors: Predina, Jarrod D.; Newton, Andrew; Kennedy, Greg; Lee, M. Kenneth; Singhal, Sunil
• Is Part Of: Molecular imaging. Volume 16(2017)
• Publication Date: 2017-08-29
• Subjects: malignant pleural mesothelioma -- inflammation -- surgery -- intraoperative imaging; Molecular diagnosis -- Periodicals; Diagnostic imaging -- Periodicals; Molecular biology -- Periodicals; Molecular diagnosis; Diagnostic imaging; Molecular biology; Periodicals; 616.075
• DOI: 10.1177/1536012117723785
• Languages: English
• ISSNs: 1535-3508

Abstract

Malignant pleural mesothelioma is a deadly disease. Complete surgical resection provides patients with the best opportunity for long-term survival. Unfortunately, identification of disease during resection can be challenging. In this report, we describe successful intraoperative utilization of the near-infrared imaging agent, indocyanine green, to help the surgeon identify malignant disease in a patient with malignant pleural mesothelioma who had previously received neoadjuvant chemotherapy. This technology may ultimately enhance the thoracic surgeon's ability to identify small disease deposits at the time of resection.